Do-Sim Park

Do-Sim Park

Auto-generated profile, based on publicly available information

Do-Sim Park

Department of Laboratory Medicine, Wonkwang University, School of Medicine, Iksan, Jeonbuk, South Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2003 in Blood
Verified
Journal Article
Closed access
PDF file
TLTae Hoon Lee
Tae Hoon Lee
SKSun-Uk Kim
Sun-Uk Kim
SYSeong-Lan Yu
Seong-Lan Yu
SKSue Hee Kim
Sue Hee Kim
DPDo Sim Park
Do Sim Park
DYDae-Yeul Yu
Dae-Yeul Yu
Peroxiredoxins (Prxs) are a family of antioxidant proteins that reduce peroxide levels by using reducing agents such as thioredoxin. These proteins were characterized to have a number of cellular functions, including cell proliferation and differentiation and protection of specific proteins from oxidative damage. However, the physiological roles of the peroxiredoxins have not been determined. To clarify the physiological relevance of this protein type, we generated a mouse model deficient in Prx II, which is abundantly expressed in all types of cells. The Prx II–/– mice were healthy in appearance and fertile. However, they had splenomegaly caused by the congestion of red pulp with hemosiderin accumulation. Heinz bodies were detected in their peripheral blood, and morphologically abnormal cells were elevated in the dense red blood cell (RBC) fractions, which contained markedly higher levels of reactive oxygen species (ROS). The Prx II–/– mice had significantly decreased hematocrit levels, but increased reticulocyte counts and erythropoietin levels, indicative of a compensatory action to maintain hematologic homeostasis in the mice. In addition, a labeling experiment with the thiol-modifying reagent biotinylated iodoacetamide (BIAM) in Prx II–/– mice revealed that a variety of RBC proteins were highly oxidized. Our results suggest that Prx II–/– mice have hemolytic anemia and that Prx II plays a major role in protecting RBCs from oxidative stress in mice.

2 April 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KLKeunwook Lee
Keunwook Lee
KNKi Taek Nam
Ki Taek Nam
SCSung Hoon Cho
Sung Hoon Cho
PGPrathyusha Gudapati
Prathyusha Gudapati
YHYoonha Hwang
Yoonha Hwang
MBMark Boothby
Mark Boothby
Notch plays critical roles in both cell fate decisions and tumorigenesis. Notch receptor engagement initiates signaling cascades that include a phosphatidylinositol 3-kinase/target of rapamycin (TOR) pathway. Mammalian TOR (mTOR) participates in two distinct biochemical complexes, mTORC1 and mTORC2, and the relationship between mTORC2 and physiological outcomes dependent on Notch signaling is unknown. In this study, we report contributions of mTORC2 to thymic T-cell acute lymphoblastic leukemia (T-ALL) driven by Notch. Conditional deletion of Rictor, an essential component of mTORC2, impaired Notch-driven proliferation and differentiation of pre-T cells. Furthermore, NF-κB activity depended on the integrity of mTORC2 in thymocytes. Active Akt restored NF-κB activation, a normal rate of proliferation, and differentiation of Rictor-deficient pre-T cells. Strikingly, mTORC2 depletion lowered CCR7 expression in thymocytes and leukemic cells, accompanied by decreased tissue invasion and delayed mortality in T-ALL driven by Notch. Collectively, these findings reveal roles for mTORC2 in promoting thymic T cell development and T-ALL and indicate that mTORC2 is crucial for Notch signaling to regulate Akt and NF-κB.

13 April 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
BNBo-Ra Na
Bo-Ra Na
HKHye-Ran Kim
Hye-Ran Kim
IPIndre Piragyte
Indre Piragyte
HOHyun-Mee Oh
Hyun-Mee Oh
MKMin-Sung Kwon
Min-Sung Kwon
CJChang-Duk Jun
Chang-Duk Jun
The formation of an immunological synapse (IS) requires tight regulation of actin dynamics by many actin polymerizing/depolymerizing proteins. However, the significance of actin stabilization at the IS remains largely unknown. In this paper, we identify a novel function of TAGLN2—an actin-binding protein predominantly expressed in T cells—in stabilizing cortical F-actin, thereby maintaining F-actin contents at the IS and acquiring LFA-1 (leukocyte function-associated antigen-1) activation after T cell receptor stimulation. TAGLN2 blocks actin depolymerization and competes with cofilin both in vitro and in vivo. Knockout of TAGLN2 (TAGLN2−/−) reduced F-actin content and destabilized F-actin ring formation, resulting in decreased cell adhesion and spreading. TAGLN2−/− T cells displayed weakened cytokine production and cytotoxic effector function. These findings reveal a novel function of TAGLN2 in enhancing T cell responses by controlling actin stability at the IS.

31 May 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HKHyo-Jin Kim
Hyo-Jin Kim
KHKi-Eun Hwang
Ki-Eun Hwang
DPDo-Sim Park
Do-Sim Park
SOSeon-Hee Oh
Seon-Hee Oh
HJHong Young Jun
Hong Young Jun
YKYoung-Suk Kim
Young-Suk Kim
Shikonin, a natural naphthoquinone pigment purified from Lithospermum erythrorhizon, induces necroptosis in various cancer types, but the mechanisms underlying the anticancer activity of shikonin in lung cancer are not fully understood. This study was designed to clarify whether shikonin causes necroptosis in non-small cell lung cancer (NSCLC) cells and to investigate the mechanism of action. Multiplex and caspase 8 assays were used to analyze effect of shikonin on A549 cells. Cytometry with annexin V/PI staining and MTT assays were used to analyze the mode of cell death. Western blotting was used to determine the effect of shikonin-induced necroptosis and autophagy. Xenograft and orthotopic models with A549 cells were used to evaluate the anti-tumor effect of shikonin in vivo. Most of the cell death induced by shikonin could be rescued by the specific necroptosis inhibitor necrostatin-1, but not by the general caspase inhibitor Z-VAD-FMK. Tumor growth was significantly lower in animals treated with shikonin than in the control group. Shikonin also increased RIP1 protein expression in tumor tissues. Autophagy inhibitors, including methyladenine (3-MA), ATG5 siRNA, and bafilomycin A, enhanced shikonin-induced necroptosis, whereas RIP1 siRNA had no effect on the apoptotic potential of shikonin. Our data indicated that shikonin treatment induced necroptosis and autophagy in NSCLC cells. In addition, the inhibition of shikonin-induced autophagy enhanced necroptosis, suggesting that shikonin could be a novel therapeutic strategy against NSCLC.

13 May 2010 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
KHKi-Eun Hwang
Ki-Eun Hwang
KNKyoung-Suk Na
Kyoung-Suk Na
DPDo-Sim Park
Do-Sim Park
KCKeum-Ha Choi
Keum-Ha Choi
BKByoung-Ryun Kim
Byoung-Ryun Kim
학김학렬 김
학렬 김

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HSHye-Jun Shin
Hye-Jun Shin
YPYoung-Ho Park
Young-Ho Park
SKSun-Uk Kim
Sun-Uk Kim
HMHyung-Bae Moon
Hyung-Bae Moon
DPDo Sim Park
Do Sim Park
DYDae-Yeul Yu
Dae-Yeul Yu
Dysregulation of liver functions leads to insulin resistance causing type 2 diabetes mellitus and is often found in chronic liver diseases. However, the mechanisms of hepatic dysfunction leading to hepatic metabolic disorder are still poorly understood in chronic liver diseases. The current work investigated the role of hepatitis B virus X protein (HBx) in regulating glucose metabolism. We studied HBx-overexpressing (HBxTg) mice and HBxTg mice lacking inducible nitric oxide synthase (iNOS). Here we show that gene expressions of the key gluconeogenic enzymes were significantly increased in HepG2 cells expressing HBx (HepG2-HBx) and in non-tumor liver tissues of hepatitis B virus patients with high levels of HBx expression. In the liver of HBxTg mice, the expressions of gluconeogenic genes were also elevated, leading to hyperglycemia by increasing hepatic glucose production. However, this effect was insufficient to cause systemic insulin resistance. Importantly, the actions of HBx on hepatic glucose metabolism are thought to be mediated via iNOS signaling, as evidenced by the fact that deficiency of iNOS restored HBx-induced hyperglycemia by suppressing the gene expression of gluconeogenic enzymes. Treatment of HepG2-HBx cells with nitric oxide (NO) caused a significant increase in the expression of gluconeogenic genes, but JNK1 inhibition was completely normalized. Furthermore, hyperactivation of JNK1 in the liver of HBxTg mice was also suppressed in the absence of iNOS, indicating the critical role for JNK in the mutual regulation of HBx- and iNOS-mediated glucose metabolism. These findings establish a novel mechanism of HBx-driven hepatic metabolic disorder that is modulated by iNOS-mediated activation of JNK.